Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · 16 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-04 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 3,506 | $21.79 | $76,395.74 | filing |
| 2026-05-01 | ACAD | ACADIA PHARMACEUTICALS INC | Option exercise | 6,815 | — | — | filing |
| 2026-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 2,709 | $22.20 | $60,139.80 | filing |
| 2026-04-05 | ACAD | ACADIA PHARMACEUTICALS INC | Option exercise | 5,276 | — | — | filing |
| 2026-03-26 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 3,171 | $21.65 | $68,652.15 | filing |
| 2026-03-26 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 37 | $21.72 | $803.54 | filing |
| 2026-03-25 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 4,177 | $21.47 | $89,680.19 | filing |
| 2026-03-25 | ACAD | ACADIA PHARMACEUTICALS INC | Option exercise | 6,178 | — | — | filing |
| 2026-03-24 | ACAD | ACADIA PHARMACEUTICALS INC | Option exercise | 8,138 | — | — | filing |
| 2025-11-18 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 10,262 | $23.69 | $243,113.96 | filing |
| 2025-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Option exercise | 9,913 | — | — | filing |
| 2025-11-17 | ACAD | ACADIA PHARMACEUTICALS INC | Option exercise | 9,913 | — | — | filing |
| 2025-09-15 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 3,498 | $23.65 | $82,727.70 | filing |
| 2025-09-15 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 3,498 | $23.65 | $82,727.70 | filing |
| 2025-09-12 | ACAD | ACADIA PHARMACEUTICALS INC | Award | 6,815 | $0.00 | $0.00 | filing |
| 2025-08-18 | ACAD | ACADIA PHARMACEUTICALS INC | Sale | 22,000 | $25.18 | $554,023.80 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.